(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MYDIALYSISCARE.COM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MYDIALYSISCARE.COM

ST13

US500000077171668

Class

44

Filing

77171668

Registration

3355955

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

35

Latest update

05/23/2024

Trademark type

Word

Nice classes

44

Filing date

05/03/2007

Registration date

12/18/2007

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/12/2018

Last transaction

01/12/2018

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

04/26/2007

First use in commerce

04/26/2007

Drawing code

4

Owner type

16

Owner location

HAMILTON, US

Examiner

KRISP,JENNIFER MARIE

Law office

M30

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

TELEFLEX LIFE SCIENCES LLC
TELEFLEX LIFE SCIENCES LIMITED
ARROW INTERNATIONAL LLC
ARROW INTERNATIONAL, INC.
Arrow International Investment Corp.

Representatives

Kevin M. Bovard Baker & Hostetler LLP

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

Providing a website featuring educational information for consumers in the field of hemodialysisvascular access and catheter use

Publications

History of USPTO decisions and trademark events.

35 publications found

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

05/23/2024

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

03/13/2024

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

02/09/2022

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

08/12/2020

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

02/13/2019

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

01/12/2018

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

01/12/2018

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

01/12/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/12/2018

E89R

TEAS SECTION 8 & 9 RECEIVED

12/14/2017

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

12/18/2016

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/31/2015

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/31/2015

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

04/25/2014

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

04/25/2014

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/25/2014

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

04/11/2014

E815

TEAS SECTION 8 & 15 RECEIVED

04/11/2014

R.PR

REGISTERED-PRINCIPAL REGISTER

12/18/2007

PUBO

PUBLISHED FOR OPPOSITION

10/02/2007

NPUB

NOTICE OF PUBLICATION

09/12/2007

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

08/30/2007

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/29/2007

XAEC

EXAMINER'S AMENDMENT ENTERED

08/29/2007

ALIE

ASSIGNED TO LIE

08/29/2007

CNEA

EXAMINERS AMENDMENT MAILED

08/29/2007

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/28/2007

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/24/2007

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/24/2007

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/24/2007

CNRT

NON-FINAL ACTION MAILED

08/08/2007

CNRT

NON-FINAL ACTION WRITTEN

08/07/2007

DOCK

ASSIGNED TO EXAMINER

07/31/2007

MPMK

NOTICE OF PSEUDO MARK MAILED

05/08/2007

NWAP

NEW APPLICATION ENTERED

05/07/2007

Continuous trademark protection

Get notified about every new filing that threatens MYDIALYSISCARE.COM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.